Myeloproliferative neoplasms trials in France
40 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 4RecruitingTrial-stage medicine
Asciminib Roll-over Study
- Where
- Bordeaux, Caen Cedex 9, Clermont-Ferrand, Lille, Lyon, Marseille, Nantes Cedex 1, Nice, Paris, Poitiers, Strasbourg Cedex 2, Toulouse, Vandoeuvre Les Nancy
- Age
- 7 years to 100 years
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522EU 2023-507557-16-00Registry updated 2026-11-09
Phase 3RecruitingTrial-stage medicine
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
- Where
- Amiens Cedex 1, Angers, Brest, Le Kremlin-Bicetre, Lens, Marseille, Nancy, Nice, Nimes Cedex 9, Paris, Pessac, Pierre-Bénite, Poitiers, Rennes, Saint-Priest-en-Jarez, Strasbourg Cedex 2, Toulouse Cedex 9
- Age
- 18 years and over
- People
- 460 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07357727EU 2025-523555-66-00Registry updated 2026-11-06
Phase 3RecruitingTrial-stage medicine
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
- Where
- Brest, Lille, Marseille, Nice, Paris, Pessac, Pierre-Bénite, Poitiers, Strasbourg Cedex 2
- Age
- 18 years and over
- People
- 324 worldwide
- Run by
- Takeda
See details and how to joinNCT07623161EU 2026-525660-17-00Registry updated 2026-11-06
Phase 3RecruitingTrial-stage medicine
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
- Where
- Amiens, Bordeaux, Brest, Créteil, Le Kremlin-Bicêtre, Nice, Paris, Poitiers, Toulouse
- Age
- 18 years and over
- People
- 426 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07623200EU 2026-525398-38-00Registry updated 2026-11-05
Phase 1RecruitingTrial-stage medicine
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
- Where
- Paris, Pierre-Bénite, Toulouse
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06150157EU 2023-505584-36-00Registry updated 2026-11-04
Phase 2RecruitingTrial-stage medicine
Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
- Where
- Angers, Brest, Nice, Nimes Cedex 9, Paris, Pierre-Bénite, Poitiers
- Age
- 18 years and over
- People
- 68 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06517875EU 2024-518225-15-00Registry updated 2026-11-04
Phase 1RecruitingTrial-stage medicine
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
- Where
- Bordeaux, Paris, Villejuif
- Age
- 18 years and over
- People
- 218 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07441694EU 2026-525217-31-00Registry updated 2026-10-30
No phaseRecruitingResearch participation
Functional and Phenotypic Characterization of Monocytes in Myeloproliferative Syndromes
- Where
- Angers, Cholet, Saumur
- Age
- 18 years and over
- People
- 70
- Run by
- University Hospital, Angers
See details and how to joinNCT06361641Registry updated 2026-10-29
Phase 3RecruitingTrial-stage medicine
INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)
- Where
- Angers, Brest, Clermont-Ferrand, Marseille, Nice, Nimes Cedex 9, Pierre-Bénite, Rennes Cedex 9, Saint-Priest-en-Jarez, Toulouse Cedex 9, Vandoeuvre Les Nancy
- Age
- 18 years and over
- People
- 250 worldwide
- Run by
- Ono Pharmaceutical Co., Ltd.
See details and how to joinNCT07429266EU 2025-524669-25-00Registry updated 2026-10-29
Phase 1RecruitingTrial-stage medicine
A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
- Where
- Nice, Paris, Toulouse Cedex 9
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- Prelude Therapeutics Incorporated
See details and how to joinNCT07469891EU 2026-525484-40-00Registry updated 2026-10-29
No phaseRecruitingResearch participation
Feasibility Trial of Extracorporeal Iron Purification in Patients With Myelodysplastic Syndrome or Myelofibrosis
- Where
- Oullins-Pierre-Bénite
- Age
- 18 years and over
- People
- 13
- Run by
- Hospices Civils de Lyon
See details and how to joinNCT06781099Registry updated 2026-10-13
Phase 1RecruitingTrial-stage medicine
A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
- Where
- Paris
- Age
- 18 years and over
- People
- 256 worldwide
- Run by
- Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
See details and how to joinNCT06343805EU 2025-522033-64-00Registry updated 2026-10-09
Phase 1/2RecruitingTrial-stage medicine
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
- Where
- Amiens, Angers, Nice, Nimes Cedex 9, Paris, Pierre-Bénite, Poitiers, Villejuif
- Age
- 18 years and over
- People
- 240 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT04176198EU 2022-502597-16-00Registry updated 2026-10-02
Phase 2RecruitingResearch participation
A Phase 2 study to evaluate the efficacy and safety of selinexor monotherapy in subjects with JAK inhibitor-naïve myelofibrosis and moderate thrombocytopenia.
- Where
- Angers, Bordeaux, Nîmes, Paris, Pierre-Bénite, Saint-Priest-en-Jarez, Tours Cedex 9
- Age
- 18 years and over
- People
- 38 worldwide
- Run by
- Karyopharm Therapeutics Inc.
See details and how to join2024-511309-47-00EU 2024-511309-47-00Registry updated 2026-09-25
Phase 2Enrolling by invitationTrial-stage medicine
RVU120 Rollover Study
- Where
- Nice, Pessac
- Age
- 18 years and over
- People
- 14 worldwide
- Run by
- Ryvu Therapeutics SA
See details and how to joinNCT06987058EU 2025-521673-14-00Registry updated 2026-09-17
Phase 2RecruitingTrial-stage medicine
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- Where
- Paris, Poitiers, Toulouse
- Age
- 18 years and over
- People
- 140 worldwide
- Run by
- Cogent Biosciences, Inc.
See details and how to joinNCT04996875EU 2024-511407-42-00Registry updated 2026-09-15
Phase 3RecruitingResearch participation
Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis
- Where
- Amiens Cedex 1, Angers, Brest, Lille Cedex, Lyon, Nantes, Nice, Nîmes, Paris, Pessac, Pierre-Bénite, Poitiers, Strasbourg Cedex 2, Toulouse, Tours
- Age
- 18 years and over
- People
- 126 worldwide
- Run by
- Kartos Therapeutics Inc.
See details and how to join2023-504724-25-00EU 2023-504724-25-00Registry updated 2026-09-14
Phase 1/2RecruitingTrial-stage medicine
A Study of BGB-11417 in Participants With Myeloid Malignancies
- Where
- Lille Cedex, Nice, Paris
- Age
- 18 years and over
- People
- 260 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT04771130EU 2023-508881-14-00Registry updated 2026-09-14
Phase 3RecruitingTrial-stage medicine
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
- Where
- Angers, Créteil, La Tronche, Lille, Marseille, Paris, Pessac, Pierre-Bénite, Strasbourg, Toulouse, Tours
- Age
- 18 years and over
- People
- 665 worldwide
- Run by
- Celgene
See details and how to joinNCT04064060Registry updated 2026-07-01
Phase 2RecruitingTrial-stage medicine
A Phase 2 Study to Assess STP938 (Dencatistat) as a Monotherapy in Adults With High Risk Essential Thrombocythaemia - The VECTRA Trial
- Where
- Brest, Marseille, Nantes, Nice, Nîmes, Paris, Poitiers, Villejuif
- Age
- 18 years and over
- People
- 50 worldwide
- Run by
- Step Pharma, SAS
See details and how to joinNCT06786234Registry updated 2026-06-16
No phaseRecruitingResearch participation
Evaluation of Optical Genome Mapping in Phi Negative Myeloproliferative Neoplasia in the Detection of Acquired Cytogenetic Abnormalities
- Where
- Amiens
- Age
- 18 years and over
- People
- 300
- Run by
- Centre Hospitalier Universitaire, Amiens
See details and how to joinNCT05714592Registry updated 2026-05-28
No phaseRecruitingResearch participation
Mechanism of Action of Interferon in the Treatment of Myeloproliferative Neoplasms
- Where
- Villejuif
- Age
- 18 years and over
- People
- 80
- Run by
- Institut National de la Santé Et de la Recherche Médicale, France
See details and how to joinNCT05850273Registry updated 2026-04-14
Phase 3RecruitingTrial-stage medicine
Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
- Where
- Amiens Cedex 1, Angers, Argenteuil Cedex, Nice, Paris, Saint-Quentin, Tours Cedex 9, Troyes
- Age
- 18 years and over
- People
- 220 worldwide
- Run by
- Italfarmaco
See details and how to joinNCT06093672EU 2022-502276-23-00Registry updated 2026-03-25
No phaseNot yet recruitingResearch participation
Clonal Hematopoiesis of Immunological Significance
- Where
- Paris
- Age
- 18 years and over
- People
- 5,000
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT05969821Registry updated 2026-03-23
Phase 3RecruitingTrial-stage medicine
AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms
- Where
- Angers, Annecy, Argenteuil, Avignon, Bayonne, Béziers, Bordeaux, Brest, Cesson-Sévigné, Clermont-Ferrand, Créteil, Grenoble, La Roche-sur-Yon, Le Havre, Le Mans, Libourne, Limoges, Lyon, Montpellier, Morlaix, Nancy, Nantes, Orléans, Paris, Périgueux, Perpignan, Quimper, Rennes, Rochefort, Roubaix, Rouen, Saint-Denis, Saint-Pierre, Saint-Priest-en-Jarez, Strasbourg, Tours, Vannes, Versailles, Villejuif, Villeurbanne
- Age
- 18 years and over
- People
- 1,308
- Run by
- University Hospital, Brest
See details and how to joinNCT05198960Registry updated 2026-03-20
All Myeloproliferative neoplasms trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.